Bookmark and Share
bortezomib (CID 387447) - Compound BioActivity Data
.
BioActivity Outcomes:
Active(639)
 
 
Inactive(115)
 
 
Inconclusive(58)
 
 
Unspecified(708)
 
 
Top Targets:
Tryp SPc(18)
 
 
 
proteasome be..(17)
 
 
 
NR LBD ER(14)
 
 
 
NR LBD AR(14)
 
 
 
 
NR LBD PPAR(10)
 
 
 
BioAssay Types:
Confirmatory(550)
 
 
 
 
Literature(417)
 
 
 
 
Summary(39)
 
 
 
 
Screening(4)
 
 
BioActivity Types:
IC50(444)
 
 
 
Potency(168)
 
 
 
 
Ki(14)
 
 
EC50(2)
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 1432    Data Row: 1520   Total Pages: 76   Display: Page     
Sort: [Click the result table header to sort]
#SubstanceActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID103338073]
IC50 2.1e-06SANGER: Inhibition of human ES6 cell growth in a cell viability assay. [AID742150, Type: confirmatory]
View
2
[SID103338073]
IC50 0.000161Inhibition of chymotrypsin-like activity of mouse liver 20S proteasome [AID452098, Type: Literature]
View
3
[SID103338073]
IC50 0.000163SANGER: Inhibition of human SK-UT-1 cell growth in a cell viability assay. [AID741882, Type: confirmatory]
View
4
[SID103338073]
IC50 0.000173SANGER: Inhibition of human SH-4 cell growth in a cell viability assay. [AID741856, Type: confirmatory]
View
5
[SID103338073]
IC50 0.000182SANGER: Inhibition of human TE-9 cell growth in a cell viability assay. [AID742018, Type: confirmatory]
View
6
[SID103338073]
IC50 0.0002Inhibition of chymotrypsin-like activity of 20S proteasome in human DLD1 cells transfected with 4Ub-Luc gene using Succinyl-Leu-Leu-Val-Tyr-AMC as substrate after 6 hrs by spectrofluorometric analysis [AID640521, Type: Literature]
View
7
[SID103338073]
IC50 0.000208SANGER: Inhibition of human A253 cell growth in a cell viability assay. [AID741945, Type: confirmatory]
View
8
[SID103338073]
IC50 0.00021SANGER: Inhibition of human no-10 cell growth in a cell viability assay. [AID742052, Type: confirmatory]
View
9
[SID103338073]
IC50 0.000216SANGER: Inhibition of human MMAC-SF cell growth in a cell viability assay. [AID742370, Type: confirmatory]
View
10
[SID103338073]
IC50 0.000225SANGER: Inhibition of human A101D cell growth in a cell viability assay. [AID741941, Type: confirmatory]
View
11
[SID103338073]
IC50 0.000243SANGER: Inhibition of human NTERA-S-cl-D1 cell growth in a cell viability assay. [AID741784, Type: confirmatory]
View
12
[SID103338073]
IC50 0.00025SANGER: Inhibition of human 8-MG-BA cell growth in a cell viability assay. [AID741938, Type: confirmatory]
View
13
[SID103338073]
IC50 0.000258SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay. [AID742277, Type: confirmatory]
View
14
[SID103338073]
IC50 0.000269SANGER: Inhibition of human LXF-289 cell growth in a cell viability assay. [AID742333, Type: confirmatory]
View
15
[SID103338073]
IC50 0.000289SANGER: Inhibition of human OVCAR-4 cell growth in a cell viability assay. [AID741799, Type: confirmatory]
View
16
[SID103338073]
IC50 0.000293SANGER: Inhibition of human LOUCY cell growth in a cell viability assay. [AID742320, Type: confirmatory]
View
17
[SID103338073]
IC50 0.000304SANGER: Inhibition of human BB65-RCC cell growth in a cell viability assay. [AID741971, Type: confirmatory]
View
18
[SID103338073]
IC50 0.000329SANGER: Inhibition of human D-542MG cell growth in a cell viability assay. [AID742108, Type: confirmatory]
View
19
[SID103338073]
IC50 0.00033SANGER: Inhibition of human ONS-76 cell growth in a cell viability assay. [AID741795, Type: confirmatory]
View
20
[SID103338073]
IC50 0.000335SANGER: Inhibition of human BB30-HNC cell growth in a cell viability assay. [AID741969, Type: confirmatory]
View